Torrent Pharmaceuticals Ltd gets Form 483 from USFDA after Pre-Approval Inspection for Bileshwarpura facility

The USFDA conducted a Pre-Approval Inspection (PAI) at Torrent Pharmaceuticals Ltd's Oral-Oncology manufacturing facility situated in Bileshwarpura, Gujarat from 05-Dec-23 to 11-Dec-23.

At the end of the inspection, the Company was issued a Form 483 with 5 procedural observations. There was no observation related to data integrity reported. We will respond to the USFDA within the prescribed timeframe and will work in close collaboration with the agency to address the observations at the earliest possible time.

Shares of Torrent Pharmaceuticals Limited was last trading in BSE at Rs. 2053.75 as compared to the previous close of Rs. 2101.40. The total number of shares traded during the day was 7331 in over 1293 trades.

The stock hit an intraday high of Rs. 2110.45 and intraday low of 2043.30. The net turnover during the day was Rs. 15112936.00.

Source : Equity Bulls

Keywords

TorrentPharmaceuticals INE685A01028 USFDA PreApprovalInspection Oral Oncology ManufacturingFacility